UM

Browse/Search Results:  1-5 of 5 Help

Selected(0)Clear Items/Page:    Sort:
First Synthesis of an Oridonin-Conjugated Iridium(III) Complex for the Intracellular Tracking of NF-kappa B in Living Cells Journal article
Wang, Wanhe, Yang, Chao, Lin, Sheng, Vellaisamy, Kasipandi, Li, Guodong, Tan, Weihong, Leung, Chung-Hang, Ma, Dik-Lung. First Synthesis of an Oridonin-Conjugated Iridium(III) Complex for the Intracellular Tracking of NF-kappa B in Living Cells[J]. CHEMISTRY-A EUROPEAN JOURNAL, 2017, 23(20), 4929-4935.
Authors:  Wang, Wanhe;  Yang, Chao;  Lin, Sheng;  Vellaisamy, Kasipandi;  Li, Guodong; et al.
Favorite | TC[WOS]:31 TC[Scopus]:33  IF:3.9/4.1 | Submit date:2018/10/30
Cell Imaging  Iridium(Iii) Complex  Natural Products  Nf-kappa b  
First Synthesis of an Oridonin-Conjugated Iridium(III) Complex for the Intracellular Tracking of NF-κB in Living Cells Journal article
Wang W., Yang C., Lin S., Vellaisamy K., Li G., Tan W., Leung C.-H., Ma D.-L.. First Synthesis of an Oridonin-Conjugated Iridium(III) Complex for the Intracellular Tracking of NF-κB in Living Cells[J]. Chemistry - A European Journal, 2017, 23(20), 4929-4935.
Authors:  Wang W.;  Yang C.;  Lin S.;  Vellaisamy K.;  Li G.; et al.
Favorite | TC[WOS]:31 TC[Scopus]:33 | Submit date:2018/11/06
Cell Imaging  Iridium(Iii) Complex  Natural Products  Nf-κb  
Complex product and system, catch-up, and sectoral system of innovation: A case study of leading medical device companies in China Journal article
Zhang L., Lam W., Hu H.. Complex product and system, catch-up, and sectoral system of innovation: A case study of leading medical device companies in China[J]. International Journal of Technological Learning, Innovation and Development, 2013, 6(3), 283-302.
Authors:  Zhang L.;  Lam W.;  Hu H.
Favorite | TC[Scopus]:10 | Submit date:2018/12/28
Complex Products  Complex Systems  Sectoral Systems Of Innovation  Ssi  Medical Devices  China  Latecomers  Catch-up Strategy  Technological Capabilities  Emerging Markets  Networking Interaction  Strategic Planning  Innovation  
Using Complex Products and Systems in the Pharmaceutical Innovation: Case study of R&D project in pharmaceutical industry Conference paper
Lu Z., Hu H.. Using Complex Products and Systems in the Pharmaceutical Innovation: Case study of R&D project in pharmaceutical industry[C], 2011, 83-87.
Authors:  Lu Z.;  Hu H.
Favorite | TC[Scopus]:0 | Submit date:2018/12/28
case study  Complex Products and Systems (CoPS)  complexity  pharmaceutical R&D project  
The natural product cyclomarin kills mycobacterium tuberculosis by targeting the ClpC1 subunit of the caseinolytic protease Journal article
Schmitt E.K., Riwanto M., Sambandamurthy V., Roggo S., Miault C., Zwingelstein C., Krastel P., Noble C., Beer D., Rao S.P.S., Au M., Niyomrattanakit P., Lim V., Zheng J., Jeffery D., Pethe K., Camacho L.R.. The natural product cyclomarin kills mycobacterium tuberculosis by targeting the ClpC1 subunit of the caseinolytic protease[J]. Angewandte Chemie - International Edition, 2011, 50(26), 5889-5891.
Authors:  Schmitt E.K.;  Riwanto M.;  Sambandamurthy V.;  Roggo S.;  Miault C.; et al.
Favorite | TC[WOS]:142 TC[Scopus]:156 | Submit date:2019/01/16
Antibiotics  Chemical Proteomics  Clp Protease Complex  Cyclic Peptides  Natural Products